Lin Cheng-Hsin, Hsu Ron-Bin
Division of Cardiovascular Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University;
Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Acta Cardiol Sin. 2014 Nov;30(6):514-21. doi: 10.6515/acs20140630a.
Infected aneurysm of the aorta and adjacent arteries is rarely occurring and can be fatal without surgical intervention. Within the medical community, the most efficacious treatment strategy to address infected aortic aneurysm remains controversial. In this study, we have reviewed our treatment experience with 109 patients.
We included in our study all consecutive patients treated for primary infected aortic aneurysm at our facility between 1995 and 2011. Aneurysm-related mortality was defined as the presence of in-hospital and late mortality related to infection or postoperative complications.
The median patient age was 72 years (range, 35-88), and 87 (80%) were male. Pathogen was isolated in 101 patients, and the most common microorganism identified was non-typhoid Salmonella in 61 (60%), followed by Staphylococcus aureus in 16 (16%) and Streptococci species in 7 (7%). Eighty-five (78%) patients underwent surgical treatment. Surgery included open repair with in-situ graft replacement in 77 (71%) and endovascular repair in 8 (7%). The aneurysm-related mortality rate was 67% in medically treated and 21% in surgically treated patients, with a median follow-up duration of 31.5 months (range 1-189). Additionally, risk factors for aneurysm-related mortality included old age, chronic lung disease, psoas muscle abscess, short duration of preoperative antibiotics, no operation, and probably endovascular repair.
Non-typhoid Salmonella was the most common pathogen found in our study group patients with infected aortic aneurysm. It appears that prolonged preoperative antibiotic treatment followed by open in-situ graft replacement remains the preferred and most effective treatment strategy.
Infected aortic aneurysm; Outcome; Pathogen; Surgery.
主动脉及相邻动脉感染性动脉瘤很少见,若不进行手术干预可能致命。在医学界,针对感染性主动脉瘤的最有效治疗策略仍存在争议。在本研究中,我们回顾了109例患者的治疗经验。
我们纳入了1995年至2011年在我们机构接受原发性感染性主动脉瘤治疗的所有连续患者。动脉瘤相关死亡率定义为与感染或术后并发症相关的住院和晚期死亡率。
患者年龄中位数为72岁(范围35 - 88岁),87例(80%)为男性。101例患者分离出病原体,最常见的微生物是61例(60%)的非伤寒沙门氏菌,其次是16例(16%)的金黄色葡萄球菌和7例(7%)的链球菌属。85例(78%)患者接受了手术治疗。手术包括77例(71%)原位移植置换的开放修复和8例(7%)的血管腔内修复。药物治疗患者的动脉瘤相关死亡率为67%,手术治疗患者为21%,中位随访时间为31.5个月(范围1 - 189个月)。此外,动脉瘤相关死亡的危险因素包括老年、慢性肺病、腰大肌脓肿、术前抗生素使用时间短、未手术以及可能的血管腔内修复。
非伤寒沙门氏菌是我们研究组感染性主动脉瘤患者中最常见的病原体。术前延长抗生素治疗后进行原位移植置换开放修复似乎仍是首选且最有效的治疗策略。
感染性主动脉瘤;结果;病原体;手术